The TGF-β1 Signaling Pathway as an Attractive Target in the Fibrosis Pathogenesis of Sjögren’s Syndrome
Transforming growth factor β1 (TGF-β1) plays a crucial role in the induction of fibrosis, often associated with chronic phases of inflammatory diseases contributing to marked fibrotic changes that compromise normal organ function. The TGF-β1 signal exerts its biological effects via the TGF-β/SMAD/Sn...
Saved in:
| Main Authors: | Margherita Sisto, Loredana Lorusso, Giuseppe Ingravallo, Roberto Tamma, Domenico Ribatti, Sabrina Lisi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2018/1965935 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Updates on Inflammatory Molecular Pathways Mediated by ADAM17 in Autoimmunity
by: Margherita Sisto, et al.
Published: (2024-12-01) -
Epigenetic Modulations of Non-Coding RNAs: A Novel Therapeutic Perspective in Sjӧgren’s Syndrome
by: Margherita Sisto, et al.
Published: (2024-11-01) -
Fibrosis in PCLS: comparing TGF-β and fibrotic cocktail
by: Carlos Machahua, et al.
Published: (2025-01-01) -
TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
by: Weili Wang, et al.
Published: (2025-06-01) -
Dalbergioidin Ameliorates Doxorubicin-Induced Renal Fibrosis by Suppressing the TGF-β Signal Pathway
by: Xianguo Ren, et al.
Published: (2016-01-01)